Nicotine Use Disorder
31
10
10
13
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
12 trials with published results (39%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
12.9%
4 terminated out of 31 trials
76.5%
-10.0% vs benchmark
10%
3 trials in Phase 3/4
92%
12 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (31)
Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Smoking Cessation and Menstrual Cycle Phase
Temporal Interference Methods for Addiction Treatment
Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
Effects of E-Cigarette Flavors on Adults TCORS 2.0
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
Identify the Optimal TMS Target to Modulate Reward Activity
tDCS Plus Varenicline for Smoking Cessation
Temporal Interference Neurostimulation and Addiction
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
Behavioral Memory Modulation in Nicotine Addiction
Neurobiology of Alcohol and Nicotine Co-Addiction
Neural Basis of Eating Behavior in Abstinent Smokers
Real-time eCounselling for Nicotine Addiction
Effects of E-cigarette Flavors on Youth TCORS 2.0
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Evaluation of the Addictive Potential of E-Cigarettes
Nicotine Virtual Reality Conditioned Place Preference
Helping Poor Smokers Quit